Celltrion, 21,035 Shares Net Sold by Foreigners in Last 5 Days... Stock Price 309,000 Won (-0.64%)

As of 11:30 AM on the 7th, Celltrion is trading at 309,000 KRW, down 0.64% from the previous day. The trading volume is 342,707 shares, which is about 41.74% of the previous day's volume. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

On August 6, researcher Oh Byung-yong from Hanyang Securities stated, "Next year, the high-concentration (40mg/0.4mL) Humira biosimilar (CT-P17) is scheduled for launch. The biosimilar market, where only a few products have been released so far, is still in its early blooming stage, and Celltrion is a leading player in this market. There are fewer than 10 global competitors. Therefore, the high valuation can be justified, and in fact, at the current stage, the valuation multiple may not hold much significance. Although the stock price has risen since COVID-19, significant long-term growth seems natural. We expect a positive stock price trend going forward." He set Celltrion's target price at 380,000 KRW.

Over the past five days, individual investors have net purchased 15,795 shares of Celltrion, while foreign investors and institutions have net sold 21,035 shares and 9,590 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.